Safer Conception Intervention for HIV-1 Serodiscordant Couples

CompletedOBSERVATIONAL
Enrollment

74

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

May 31, 2018

Study Completion Date

July 31, 2018

Conditions
HIV SeropositivityPregnancy, High-Risk
Interventions
DRUG

PrEP

An integrated, phased safer conception intervention that focuses on ART use by the HIV-1 infected partner, PrEP use by the HIV-1 uninfected partner, and timed condomless sex during the peri-conception period.

BEHAVIORAL

Counseling on timed condomless sex, ART and PrEP adherence

An integrated, phased safer conception intervention that focuses on ART use by the HIV-1 infected partner, PrEP use by the HIV-1 uninfected partner, and timed condomless sex

Trial Locations (2)

98104

University of Washington, Coordinating Center, Seattle

Unknown

Partners in Health, Research and Development, Thika

All Listed Sponsors
collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

collaborator

Fogarty International Center of the National Institute of Health

NIH

lead

University of Washington

OTHER

NCT03030768 - Safer Conception Intervention for HIV-1 Serodiscordant Couples | Biotech Hunter | Biotech Hunter